Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Anti-IL-17 vergroot kans op Candida-infectie
nov 2021 | Arthritis psoriatica, Psoriasis, Schimmelinfecties